Three years of Elexacaftor/tezacaftor/ivacaftor decreases the presence of pathogens in sputum cultures and throat swabs - Amsterdam 2025

Cystic fibrosis research: changing the landscape

Chair(s): Chiara Premuda, Pilar Azevedo Cardim

Session type: Poster session

Three years of Elexacaftor/tezacaftor/ivacaftor decreases the presence of pathogens in sputum cultures and throat swabs

Simon Dekker

EVENTS HOME

Poster
Abstract

Previous presentation

Next presentation

Session content

Azole-Resistant Aspergillus fumigatus in Patients with Cystic Fibrosis, a Prospective Study

Atefeh Fakharian

Poster

Abstract

Investigation of voriconazole plasma level (vpl) measurement in cystic fibrosis (cf) patients diagnosed with pulmonary aspergillosis (pa) and allergic bronchopulmonary aspergillosis

Hande Yuce Ozdemir

Poster

Abstract

The association of gene modulator therapy and fat-soluble vitamin levels in adults with cystic fibrosis

Aysu Yalman

Poster

Abstract

Pulmonary Aspergilloma in Cystic Fibrosis

Maitreyi Penugonda

Poster

Abstract

Three years of Elexacaftor/tezacaftor/ivacaftor decreases the presence of pathogens in sputum cultures and throat swabs

Simon Dekker

Poster

Abstract

Affective temperament and treatment adherence in adult cystic fibrosis a pilot study

Severin Pötscher

Poster

Abstract

Discovery of pro-inflammatory mediators of Pseudomonas aeruginosa expressed under in vivo-like conditions in chronic cystic fibrosis infection

Merel Wauters

Poster

Abstract

Airway microbiology trends in Cystic Fibrosis patients: A comparative study between 2019 and 2023

Francisca Trigueiros Pinção Nieto Guimarães

Poster

Abstract

In vitro assay for personalized and effective medicine of Cystic Fibrosis

Gabriela Hoefel

Poster

Abstract

CFTR mRNA delivery with a novel non-LNP nanoemulsion formulation to cystic fibrosis differentiated human airway epithelium and airway organoid

Shyreen Hassibi

Poster

Abstract

Group psychotherapy for anxiety, depression, and quality of life in Cystic Fibrosis

Eda Esra Baysal

Poster

Abstract

Steps in developing the ICF core set for adults with cystic fibrosis: health professional and patient perspectives

Nisa Akyazi

Poster

Abstract

Impact of CFTR modulators on chronic and intermittent bronchial infection

Sophie Gohy

Poster

Abstract

Personalized Dosing of ELE/TEZ/IVA in Cystic Fibrosis: integrating pharmacokinetics and pharmacogenetics for Improved Outcomes

Sylvie Leroy

Poster

Abstract

Evaluating regional ventilation abnormalities in patients with cystic fibrosis results from the ReVEAL-CF study.

Grace Kavanagh

Poster

Abstract

Functional and clinical effect of intermittent intrapulmonary deflation versus autogenic drainage for airway clearance in cystic fibrosis: MUCOSIM trial

Thierry Perez

Poster

Abstract

Respiratory rate measured by high-adherence wearable correlates with clinical predictors of pulmonary exacerbation in cystic fibrosis patients

Carlos Milla

Poster

Abstract

CDN Connection Issue

The ERS Congress 2025, Amsterdam

#{title}